Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
06/27/2012 | EP2468287A1 Macrocyclic hepatitis c serine protease inhibitors |
06/27/2012 | EP2468286A1 Macrocyclic hepatitis C serine protease inhibitors |
06/27/2012 | EP2468285A1 Macrocyclic hepatitis C serine protease inhibitors |
06/27/2012 | EP2468280A1 Use of prokineticin 1 receptor agonists to promote the differentiation of epicardin+ progenitor cells |
06/27/2012 | EP2467477A2 Fast acting snare-cleaving enzymes |
06/27/2012 | EP2467399A1 Purification of vwf for increased removal of non-lipid enveloped viruses |
06/27/2012 | EP2467166A2 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
06/27/2012 | EP2467163A2 Mimotopes of hiv and uses thereof |
06/27/2012 | EP2467154A2 Tumoricidal, bactericidal, or viricidal macrophage activation |
06/27/2012 | EP2467153A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases |
06/27/2012 | EP2467152A1 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes |
06/27/2012 | EP2467144A1 Combination of proteasome inhibitors and anti-hepatitis medication for treating hepatitis |
06/27/2012 | EP2246360B1 Compositions for the treatment of gastrointestinal disorders |
06/27/2012 | EP2120985B1 FN-38 peptides for use in the treatment of psychotic and anxiety disorders |
06/27/2012 | EP2026830B1 Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis |
06/27/2012 | EP2012816B1 Use of thymosin 1, alone or in combination with ptx3 or ganciclovir, for the treatment of cytomegalovirus infection |
06/27/2012 | EP1988163B1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
06/27/2012 | EP1765065B1 Methods and compositions related to delivery of chemical compounds to invertebrate embryos |
06/27/2012 | EP1722834B1 Matrix comprising naturally-occurring crosslinked protein backbone |
06/27/2012 | EP1692187B1 EC SOD and cell transducing EC SOD and use thereof |
06/27/2012 | EP1670449B1 Thyroid hormone analogs and methods of use in angiogenesis |
06/27/2012 | EP1034277B1 Extracellular matrix-binding proteins from Staphylococcus aureus |
06/27/2012 | CN102517387A Application of MVP used as antiviral drug target |
06/27/2012 | CN102517366A Fish skin collagen hydrolysate, its preparation method and application |
06/27/2012 | CN102516399A Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
06/27/2012 | CN102516397A Interleukin-17 receptor antagonist and application thereof in preparing anti-myocardial fibrosis medicine |
06/27/2012 | CN102516393A Insulin mimetic peptide fusion protein, mutant and applications thereof |
06/27/2012 | CN102516386A Il-21 derivatives |
06/27/2012 | CN102516384A MLKL protein and application of MLKL protein as target point of cell necrosis inhibitor |
06/27/2012 | CN102516382A Antimicrobial peptide Hainanenin-5 of Amolops hainanensis, gene of antimicrobial peptide Hainanenin-5 of Amolops hainanensis, separation and purification method and chemical synthesis method for antimicrobial peptide Hainanenin-5 of Amolops hainanensis and application of gene of antimicrobial peptide Hainanenin-5 of Amolops hainanensis |
06/27/2012 | CN102516368A Cyclopeptide-7 compounds and application thereof in preparation of anti-tumor medicines |
06/27/2012 | CN102516366A Th1 cell factor immunoregulation polypeptide and application thereof |
06/27/2012 | CN102516365A Anti-HIV (human immunodeficiency virus) polypeptide of Tibetan dolphin scorpion |
06/27/2012 | CN102516364A Active peptide for simulating porcine growth hormone-like effect, preparation method for active peptide and application of active peptide |
06/27/2012 | CN102516360A Polypeptide capable of inhibiting beta-secretase digestion effect and application thereof |
06/27/2012 | CN102516358A Angiotensin I transferase inhibitor derived from scale collagen and application thereof |
06/27/2012 | CN102516357A Polypeptide combined with A-beta amyloid and application thereof |
06/27/2012 | CN102516356A Epitope polypeptide applicable to mycobacterium tuberculosis infection detection and application thereof |
06/27/2012 | CN102516355A Peptide derivative of benzfuran quinoline and preparation method thereof and application thereof as antitumor medicament |
06/27/2012 | CN102512669A Female whitening skin-nourishing composition |
06/27/2012 | CN102512668A Lyophilized powder of adenosine disodium triphosphate, coenzyme A and insulin for injection and preparation method thereof |
06/27/2012 | CN102512667A Lipid composition of insulin, preparation method thereof, and preparation thereof |
06/27/2012 | CN102512666A Application of interferon lambda1 in preparation of anti-enterovirus 71 medicines |
06/27/2012 | CN102512665A Therapeutic agent for blood-related disease containing epo derivative |
06/27/2012 | CN102512664A Nerve growth factor composition |
06/27/2012 | CN102512663A Application of nerve growth factor in preparing medicines for treating pruritus |
06/27/2012 | CN102512662A Protein containing 36-83 amino acid motifs in Coxsackie B3virus 2B protein and application thereof |
06/27/2012 | CN102512661A Protein containing 1st to 79th sites of amino acid basic sequences in protein 2C of coxsackievirus B3 and application for same |
06/27/2012 | CN102512660A Protein containing 51st to 89th sites of amino acid basic sequences in protein 3A of coxsackievirus B3 and application for same |
06/27/2012 | CN102512659A Medicinal composition containing echinocandin antifungal agent and its preparing method and its use |
06/27/2012 | CN102512658A Non-aqueous polar aprotic peptide formulations |
06/27/2012 | CN102512657A Pentagastrin liquid injection and preparation method thereof |
06/27/2012 | CN102512656A Quinapril hydrochloride medicinal composition |
06/27/2012 | CN102512655A L-carnitine composition, L-carnitine preparation and preparation method and application thereof |
06/27/2012 | CN102512654A Swine aphrodisiac powder preparation and its preparation technology |
06/27/2012 | CN102512384A Novel freeze-dried preparation-type protein composition and preparation method thereof |
06/27/2012 | CN102512379A Novel Echinocandin antifungal pharmaceutical composition and preparation method thereof |
06/27/2012 | CN102512372A Pharmaceutical compositions |
06/27/2012 | CN102512370A HSCGF liposome as well as preparation and application thereof |
06/27/2012 | CN102512368A Production technology of metallothionein flexible nano-liposomes |
06/27/2012 | CN102512357A Nerve growth factor ophthalmic gel and preparation method thereof |
06/27/2012 | CN102228444B N(2)-L-alanyl-L-glutamine preparation for injection and preparation method thereof |
06/27/2012 | CN102188381B Preparation method of orexin-A medicament carrying liposome and medicament for treating paroxysmal sleep |
06/27/2012 | CN102113999B Novel multi-layer polysaccharide structure-modified liposome-encapsulated hemoglobin nano-capsule blood substitute |
06/27/2012 | CN102080079B Preparation method and application of novel antimicrobial peptide Misgurin mutant |
06/27/2012 | CN101914545B Leucine-rich protein ALM gene of branchiostoma japonicum and application thereof |
06/27/2012 | CN101906147B Conjugate formed by two Arg-Gly-Asp-Ser chains and one fatty alcohol chain through Lys, synthesis thereof and application in medicine |
06/27/2012 | CN101906097B 1,3-dioxane compounds as well as synthesizing method and medical application thereof |
06/27/2012 | CN101850105B Cefuroxime sodium composite medicine |
06/27/2012 | CN101850104B Clindamycin hydrochloride composition medicine |
06/27/2012 | CN101850103B Clindamycin phosphate composite medicine |
06/27/2012 | CN101850102B Sodium glucuronate composite medicine |
06/27/2012 | CN101838650B Development and applications of new human gene FAMLF in human gene recombination, malignant tumor gene detection and specific monoclonal antibody |
06/27/2012 | CN101822838B Nano-medicament carrier material for target recognition of tumor cell as well as preparation and application thereof |
06/27/2012 | CN101822818B Composition of Chinese yam polysaccharide and Chinese yam protein and application thereof |
06/27/2012 | CN101775082B Amphoteric ion-based charge reversal chitosan derivative and application thereof in medicament |
06/27/2012 | CN101704877B Method for preparing soybean peptide |
06/27/2012 | CN101613679B Rhabdovirus with recombination superoxide dismutase gene and preparation and application thereof |
06/27/2012 | CN101553568B Neukinase, a downstream protein of neuregulin |
06/27/2012 | CN101513390B Hydrochloric acid boanmycin liposomes and preparation method thereof |
06/27/2012 | CN101497651B Compound with thrombus dissolving activity, as well as preparation and use thereof |
06/27/2012 | CN101485885B Protein phosphatase PPM1E used as target for treating disease as well as use thereof and siRNA |
06/27/2012 | CN101481421B Recombinant antigen polypeptide for treating Alzheimer's disease and polypeptide gene |
06/27/2012 | CN101450966B Polypeptide of antimicrobial agent and use |
06/27/2012 | CN101445554B Wood frog anticancer peptide and preparation method thereof |
06/27/2012 | CN101428139B Method for extending spermiation period of verasper moseri |
06/27/2012 | CN101417123B Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders |
06/27/2012 | CN101374950B Improved IL-15 and IL-15R-alpha for expression in mammalian cells |
06/27/2012 | CN101333247B Antimicrobial peptide separated from skin of Northeast China brown frog and applications in antibacterials |
06/27/2012 | CN101218280B Polymeric derivative of cytidine metabolic antagonist |
06/27/2012 | CN101171262B Glucagon-like-peptide-2 (GLP-2) analogues |
06/27/2012 | CN101022822B Liquid preparation of physiologically active peptide |
06/26/2012 | USRE43497 Anti-MIF antibodies |
06/26/2012 | US8207326 Identification of novel genes coding for small temporal RNAs |
06/26/2012 | US8207299 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof |
06/26/2012 | US8207297 Compounds for enzyme inhibition |
06/26/2012 | US8207295 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
06/26/2012 | US8207294 Treatment of Aspergillus infections with alpha thymosin peptides |
06/26/2012 | US8207292 Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugs |
06/26/2012 | US8207234 Methods for treating diabetic foot ulcers |